This issue of PET Clinics focuses on PET in the Management of Hematologic Malignancies and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Gary Ulaner, Jakub Svoboda, and Lale Kostakoglu. Articles will include: PET-CR as a surrogate to replace PFS in assessment of efficacy of DLBCL treatments; PET-Derived Quantitative Metrics for Response and Prognosis; Evolving Role of PET Based Novel Quantitative Techniques in the Management of Hematological Malignancies; Critical Role of FDG/NaF imaging in Assessment of Skeletal Involvement in Patients with Multiple Myeloma; Response adapted treatment strategies in Hodgkin lymphoma using PET scans; FDG PET/CT as a staging tool in multiple myeloma; FDG PET/CT as a predictor of prognosis in multiple myeloma; PET/CT as a response evaluation tool in multiple myeloma; PET imaging in CLL and Richter’s transformation; Current Overview and Future Directions of PET for Hematologic Malignancies; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. CME-Accreditation Page - p. ix 8. Preface - p. xi 9. End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma - p. 307 10. PET-Derived Quantitative Metrics for Response and Prognosis in Lymphoma - p. 317 11. Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies - p. 331 12. Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients: Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches - p. 341 13. Response-Adapted Treatment Strategies in Hodgkin Lymphoma Using PET Imaging - p. 353 14. PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma - p. 369 15. Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma - p. 383 16. Fludeoxyglucose F 18 PET/Computed Tomography Evaluation of Therapeutic Response in Multiple Myeloma - p. 391 17. PET/Computed Tomography in Chronic Lymphocytic Leukemia and Richter Transformation - p. 405 18. PET-Computed Tomography in Myeloma: Current Overview and Future Directions - p. 411
No hay muestra disponible
No hay ficha técnica disponible
This issue of PET Clinics focuses on PET in the Management of Hematologic Malignancies and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Gary Ulaner, Jakub Svoboda, and Lale Kostakoglu. Articles will include: PET-CR as a surrogate to replace PFS in assessment of efficacy of DLBCL treatments; PET-Derived Quantitative Metrics for Response and Prognosis; Evolving Role of PET Based Novel Quantitative Techniques in the Management of Hematological Malignancies; Critical Role of FDG/NaF imaging in Assessment of Skeletal Involvement in Patients with Multiple Myeloma; Response adapted treatment strategies in Hodgkin lymphoma using PET scans; FDG PET/CT as a staging tool in multiple myeloma; FDG PET/CT as a predictor of prognosis in multiple myeloma; PET/CT as a response evaluation tool in multiple myeloma; PET imaging in CLL and Richter’s transformation; Current Overview and Future Directions of PET for Hematologic Malignancies; and more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. CME-Accreditation Page - p. ix 8. Preface - p. xi 9. End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma - p. 307 10. PET-Derived Quantitative Metrics for Response and Prognosis in Lymphoma - p. 317 11. Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies - p. 331 12. Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients: Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches - p. 341 13. Response-Adapted Treatment Strategies in Hodgkin Lymphoma Using PET Imaging - p. 353 14. PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma - p. 369 15. Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma - p. 383 16. Fludeoxyglucose F 18 PET/Computed Tomography Evaluation of Therapeutic Response in Multiple Myeloma - p. 391 17. PET/Computed Tomography in Chronic Lymphocytic Leukemia and Richter Transformation - p. 405 18. PET-Computed Tomography in Myeloma: Current Overview and Future Directions - p. 411
No hay muestra disponible
No hay ficha técnica disponible
